arrow
Back
B

Biljana Culjkovic‐Kraljacic

jewish general hospital - montreal

22H-index
46Paper Count
1.7KCitation Count
Published Papers 17
Publication Date
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine
err2023-03-23
err3
errOAAI
errAssouline, Sarit; Gasiorek, Jadwiga; Bergeron, Julie; Lambert, Caroline; Culjkovic-Kraljacic, Biljana; Cocolakis, Eftihia; Zakaria, Chadi; Szlachtycz, David; Yee, Karen; Borden, Katherine L. B.
errShare
errSave
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing
err2023-02-27
err8
errOAAI
errGhram, Mehdi; Morris, Gavin; Culjkovic-Kraljacic, Biljana; Mars, Jean-Clement; Gendron, Patrick; Skrabanek, Lucy; Revuelta, Maria Victoria; Cerchietti, Leandro; Guzman, Monica L.; Borden, Katherine L. B.
errShare
errSave
The eukaryotic translation initiation factor eIF4E elevates steady-state m7G capping of coding and noncoding transcripts
err2020-10-14
err29
errOAAI
errCuljkovic-Kraljacic, Biljana; Skrabanek, Lucy; Revuelta, Maria V.; Gasiorek, Jadwiga; Cowling, Victoria H.; Cerchietti, Leandro; Borden, Katherine L. B.
errShare
errSave
Structural studies of the eIF4E-VPg complex reveal a direct competition for capped RNA: Implications for translation
err2019-11-11
err53
errOAAI
errde Oliveira, Luciana Coutinho; Volpon, Laurent; Rahardjo, Amanda K.; Osborne, Michael J.; Culjkovic-Kraljacic, Biljana; Trahan, Christian; Oeffinger, Marlene; Kwok, Benjamin H.; Borden, Katherine L. B.
errShare
errSave
GLI1-Inducible Glucuronidation Targets a Broad Spectrum of Drugs
err2019-02-14
err15
PREAI
errZahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Gasiorek, Jadwiga; Duchaine, Jean; Borden, Katherine L. B.
errShare
errSave
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
err2018-11-26
err34
errOAAI
errUrtishak, Karen A.; Wang, Li-San; Culjkovic-Kraljacic, Biljana; Davenport, James W.; Porazzi, Patrizia; Vincent, Tiffaney L.; Teachey, David T.; Tasian, Sarah K.; Moore, Jonni S.; Seif, Alix E.; Jin, Shenghao; Barrett, Jeffrey S.; Robinson, Blaine W.; Chen, I-Ming L.; Harvey, Richard C.; Carroll, Martin P.; Carroll, Andrew J.; Heerema, Nyla A.; Devidas, Meenakshi; Dreyer, ZoAnn E.; Hilden, Joanne M.; Hunger, Stephen P.; Willman, Cheryl L.; Borden, Katherine L. B.; Felix, Carolyn A.
errShare
errSave
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity
err2017-11-07
err14
errOAAI
errZahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Emond, Audrey; Pettersson, Filippa; Midura, Ronald; Lauer, Mark; Del Rincon, Sonia; Cali, Valbona; Assouline, Sarit; Miller, Wilson H.; Hascall, Vincent; Borden, Katherine L. B.
errShare
errSave
A biochemical framework for eIF4E-dependent mRNA export and nuclear recycling of the export machinery
errRNA
IF5
err2017-03-21
err70
errOAAI
errVolpon, Laurent; Culjkovic-Kraljacic, Biljana; Sohn, Hye Seon; Blanchet-Cohen, Alexis; Osborne, Michael J.; Borden, Katherine L. B.
errShare
errSave
Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E
err2016-04-25
err48
errOAAI
errVolpon, Laurent; Culjkovic-Kraljacic, Biljana; Osborne, Michael J.; Ramteke, Anup; Sun, Qingxiang; Niesman, Ashley; Chook, Yuh Min; Borden, Katherine L. B.
errShare
errSave
A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E
err2014-11-25
err71
errOAAI
errAssouline, Sarit; Culjkovic-Kraljacic, Biljana; Bergeron, Julie; Caplan, Stephen; Cocolakis, Eftihia; Lambert, Caroline; Lau, Cara J.; Zahreddine, Hiba Ahmad; Miller, Wilson H., Jr.; Borden, Katherine L. B.
errShare
errSave
eIF4E3, a new actor in mRNA metabolism and tumor suppression
err2014-10-28
err33
errOAAI
errVolpon, Laurent; Osborne, Michael J.; Culjkovic-Kraljacic, Biljana; Borden, Katherine L. B.
errShare
errSave
Inducible drug modification: A new form of resistance
err2014-08-01
err0
errOAAI
errCuljkovic-Kraljacic, Biljana; Zahreddine, Hiba Ahmad; Borden, Katherine L. B.
errShare
errSave
Aiding and abetting cancer: mRNA export and the nuclear pore
err2013-07-01
err61
errOAAI
errCuljkovic-Kraljacic, Biljana; Borden, Katherine L. B.
errShare
errSave
The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia
errLEUKEMIA
IF13.4
err2013-03-07
err27
errOAAI
errHariri, F.; Arguello, M.; Volpon, L.; Culjkovic-Kraljacic, B.; Nielsen, T. H.; Hiscott, J.; Mann, K. K.; Borden, K. L. B.
errShare
errSave
eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition
err2013-02-19
err103
errOAAI
errOsborne, Michael J.; Volpon, Laurent; Kornblatt, Jack A.; Culjkovic-Kraljacic, Biljana; Baguet, Aurelie; Borden, Katherine L. B.
errShare
errSave
The Oncogene eIF4E Reprograms the Nuclear Pore Complex to Promote mRNA Export and Oncogenic Transformation
err2012-08-01
err126
errOAAI
errCuljkovic-Kraljacic, Biljana; Baguet, Aurelie; Volpon, Laurent; Amri, Abdellatif; Borden, Katherine L. B.
errShare
errSave